US v. Regeneron Pharmaceuticals, Inc.
| UNITED STATES |
| REGENERON PHARMACEUTICALS, INC. |
| GENENTECH, INC. and ROBERT J. TERIFAY |
| 23-2086 |
| December 22, 2023 |
| U.S. Court of Appeals, First Circuit |
| Qui Tam False Claims Act |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 22, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| CIVIL CASE docketed. Notice of appeal (doc. #375 and #379) filed by Appellant US. Appearance form due 01/05/2024. Docketing Statement due 01/05/2024. Transcript Report/Order form due 01/05/2024. [23-2086] (GRC) [Entered: 12/22/2023 03:34 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
